Abstract
We read with interest the results of the NeoPIns trial, published this year in The Lancet by Stocker and colleagues and assessing the effect of a procalcitonin (PCT) guided algorithm in early-onset neonatal sepsis in term infants (1).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
